Business Avidity Biosciences Stock Soars 9% Following Upgrade from BofA Avidity Biosciences Inc. (NASDAQ:RNA) experienced a notable surge on Friday, gaining 9.02 percent to close at $44.74 per share. This improvement comes after BofA... Editorial13 September, 2025